There's A Lot To Like About Autek China's (SZSE:300595) Upcoming CN¥0.223 Dividend
Readers hoping to buy Autek China Inc. (SZSE:300595) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one business day before
Opcom TV (300595.SZ): 2023 equity distribution, 10 installments, 2.23 yuan, share registration date May 15
Gelonghui, May 9 | Opcon TV (300595.SZ) announced that the company's 2023 equity distribution plan is to distribute RMB 2.23 in cash (tax included) to all shareholders for every 10 shares based on the company's current total share capital of 897,145,269 shares. The share registration date for this equity distribution is May 15, 2024, and the ex-dividend date is May 16, 2024.
Autek China Inc.'s (SZSE:300595) Market Cap Rose CN¥592m Last Week; Retail Investors Who Hold 35% Profited and so Did Insiders
Key Insights Autek China's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public 51% of the business is held by the top 3 share
Nomura Adjusts Autek China's Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral
03:43 AM EDT, 04/29/2024 (MT Newswires) -- Nomura Adjusts Autek China's Price Target to 19.96 Yuan From 22.16 Yuan, Keeps at Neutral Price (RMB): ¥19.14, Change: ¥+1.08, Percent Change: +5.98%
Opcom TV (300595.SZ) announced first-quarter results, net profit of 193 million yuan, up 11.39% year on year
Opcom TV (300595.SZ) released its report for the first quarter of 2024, and the company achieved revenue during the reporting period...
Opcon TV (300595.SZ): The production cost of self-produced materials is significantly lower than outsourced, which can effectively reduce the manufacturing cost of lenses
Gelonghui, April 16 | Opcon TV (300595.SZ) said on the investor interactive platform that the proportion of self-produced materials used is gradually increasing and is changing; the ultra-high permeable corneal shaping lens materials that have already been submitted for registration are self-produced. The production cost of self-produced materials is significantly lower than outsourced, which can effectively reduce the manufacturing cost of lenses.
Opcom TV (300595.SZ): As of April 10, 2024, the total number of shareholders of the company was 71,950
Gelonghui, April 12 | Opcon TV (300595.SZ) said on the investor interactive platform that as of April 10, 2024, the total number of shareholders of the company was 71,950.
Opcon TV (300595.SZ): Application for registration of “Hard Breathable Contact Lenses for Corneal Reshaping” was accepted
Gelonghui, April 10 | Opcon TV (300595.SZ) announced that the company recently received the “Notice of Acceptance” (acceptance number: CQZ2400686) from the State Drug Administration, and the company's application for registration of the medical device product “Hard Breathable Contact Lenses for Corneal Reshaping” has been accepted by the State Drug Administration.
Autek China (SZSE:300595) Could Easily Take On More Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Will Weakness in Autek China Inc.'s (SZSE:300595) Stock Prove Temporary Given Strong Fundamentals?
It is hard to get excited after looking at Autek China's (SZSE:300595) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a c
Opcom TV (300595.SZ): A steam eye mask has been launched, and sales are good
Gelonghui March 13 丨 Some investors asked Opcon TV (300595.SZ) on the investor interactive platform, “How are the benefits of cooperation with the Three Sheep?” The company replied that it has launched a steam eye mask, which is selling well, and other products are still being prepared.
Opcom Vision (300595.SZ): Its Hefei Kangshi Ophthalmology Hospital has 0.01% of the in-hospital preparation of atropine sulphate
Gelonghui, March 13 | Opticon TV (300595.SZ) said on the investor interactive platform that the company's Hefei Kangshi Ophthalmology Hospital has 0.01% of the in-hospital preparation of atropine sulfate, which began to be sold in hospitals in July 2022, and optometry center users need to go to the hospital to buy them. After 0.01% atropine sulfate approved and registered by the State Drug Administration is marketed, in-hospital preparations of the same dose will no longer be produced and will be sold as products registered by the State Drug Administration. The company's holding subsidiary, the product 0.01% of atropine sulphate registered by the National Drug Administration, is in phase III clinical phase.
Earnings Not Telling The Story For Autek China Inc. (SZSE:300595) After Shares Rise 25%
Those holding Autek China Inc. (SZSE:300595) shares would be relieved that the share price has rebounded 25% in the last thirty days, but it needs to keep going to repair the recent damage it has caus
Autek China (SZSE:300595) Investors Are Sitting on a Loss of 65% If They Invested Three Years Ago
Autek China Inc. (SZSE:300595) shareholders should be happy to see the share price up 18% in the last month. But that is small recompense for the exasperating returns over three years. Regrettably
Opcon TV (300595.SZ): The registration application for “hard scleral contact lenses” has been accepted by the China Drug Administration
Gelonghui, Feb. 19 | OpcomTV (300595.SZ) announced that it has recently received the “Notice of Acceptance” issued by the State Drug Administration. The company's application for registration of the medical device product “hard sclera contact lens” has been accepted by the State Drug Administration. Clinical research on hard scleral contact lenses has been conducted abroad for many years. Scleral contact lenses have a larger diameter than corneal contact lenses, are more comfortable to wear than corneal contact lenses, and have better vision correction effects on irregular corneas.
Be Wary Of Autek China (SZSE:300595) And Its Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding
With 33% Ownership, Autek China Inc. (SZSE:300595) Insiders Have a Lot Riding on the Company's Future
Key Insights Autek China's significant insider ownership suggests inherent interests in company's expansion A total of 3 investors have a majority stake in the company with 51% ownership Institut
Opcom TV (300595.SZ) plans to launch a 2.6999 million restricted stock incentive plan
According to Zhitong Finance App, Opcom (300595.SZ) disclosed the 2024 Restricted Stock Incentive Plan (draft). The number of restricted shares to be granted by the company's current incentive plan is 2.699,900 shares. The underlying stock types involved are RMB A shares common stock, accounting for 0.30% of the company's total share capital of 897,145,269 shares when the draft incentive plan was announced. This award is a one-time grant with no reserved rights. The grant price is 14.27 yuan/share. The total number of incentive recipients granted under this incentive plan is 69, including control by the company (including the company's subordinates when the company announced this incentive plan
Opcom Vision (300595.SZ): Expansive and deep sales are still possible, and efforts are being made to expand in the north
On December 13, Gelonghui (300595.SZ) said on the investor interactive platform on December 13 that extensive and deep sales are still possible, and efforts are being made to expand in the north.
Returns On Capital At Autek China (SZSE:300595) Paint A Concerning Picture
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst other things, we'll want to see two things; firstly, a growing return on capital em
No Data